Published in

Oxford University Press, Stem Cells, 9(37), p. 1130-1135, 2019

DOI: 10.1002/stem.3003

Links

Tools

Export citation

Search in Google Scholar

A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017

Journal article published in 2019 by Jung-Hyun Kim ORCID, Alex Alderton, Jeremy M. Crook ORCID, Nissim Benvenisty, Catharina Brandsten, Meri Firpo, Peter W. Harrison, Shin Kawamata, Eihachiro Kawase, Andreas Kurtz, Jeanne F. Loring, Tenneille Ludwig, Jennifer Man, Joanne C. Mountford, Marc L. Turner and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract This report summarizes the recent activity of the International Stem Cell Banking Initiative held at Harvard Stem Cell Institute, Boston, MA, USA, on June 18, 2017. In this meeting, we aimed to find consensus on ongoing issues of quality control (QC), safety, and efficacy of human pluripotent stem cell banks and their derivative cell therapy products for the global harmonization. In particular, assays for the QC testing such as pluripotency assays test and general QC testing criteria were intensively discussed. Moreover, the recent activities of global stem cell banking centers and the regulatory bodies were briefly summarized to provide an overview on global developments and issues. Stem Cells 2019;37:1130–1135